# Combination Chemotherapy in Treating Patients With Advanced or Metastatic Colorectal Cancer

> **NCT00030797** · PHASE2 · COMPLETED · sponsor: **Swiss Cancer Institute** · enrollment: 75 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** Irinotecan 70 mg/m2
- **DRUG:** Irinotecan 240 mg/m2

## Key facts

- **NCT ID:** NCT00030797
- **Lead sponsor:** Swiss Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-02
- **Primary completion:** 2002-05
- **Final completion:** 2003-12
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2012-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00030797

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00030797, "Combination Chemotherapy in Treating Patients With Advanced or Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00030797. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*